TITLE
- Professor
- Member of Pharmacotherapy Outcomes Research Center
- Past President Academy of Managed Care Pharmacy
- Associate Member, HCI Cancer Control and Population Sciences Research Program
- President of International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- Adjunct Professor, Department Pediatrics Population Health Science
CONTACT
Office: L. S. Skaggs Research Institute, Room 4781
Phone: (801) 581-3182
Fax: (801) 587-7923
Email: Diana.Brixner@utah.edu
Visit HCI Profile
Biography
Dr. Diana Brixner is currently a Professor in the Department of Pharmacotherapy and is a Founder of the Pharmacotherapy Outcomes Research Center at the University of Utah in Salt Lake City, Utah. She is a member of the Huntsman Cancer Institute Cancer Control and Population Sciences and the Center for Genomic Medicine. Prior to her academic appointment in 2002 she worked both in the biotech (NeoRx) and pharmaceutical (SmithKline Beechman, Novartis) Industry focused on value assessment of their technologies in the early years of the field. Dr. Brixner was a past President for both the Academy of Managed Care Pharmacy (AMCP) and International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She was recently a one-year Scholar-in-Residence for the Academy of Managed Care Pharmacy. She is also a member of the board of the International Market Access Society.
Education
- Introduction to Health Technology Assessment Certificate, University of Health Science, Hall in Tirol, Austria 2015
- Clinical Epidemiology Certificate, University of Health Sciences, Hall in Tirol, Austria, 2013
- Modeling Approaches for Health Technology Assessment Certificate, University of Health Sciences, Hall in Tirol, Austria, 2010
- University of Utah, Salt Lake City, Utah. Doctor of Philosophy in Medicinal Chemistry, 1987
- University of Rhode Island. Bachelor of Science, 1982
Research Interests
Dr. Brixner's research focus is on the design, conduct, and communication of pharmacoeconomic and outcomes research studies to demonstrate the value of pharmaceutical and related therapies from the perspective of the private and public payer. Much of her work is focused on oncology and personalized medicines. She has published over 150 articles in peer reviewed journals, authored three book chapters, has one issued patent, and has been an invited speaker at a variety of national and international professional meetings. She is also a principal of the Millcreek Outcomes Group, LLC where she focuses on activities to communicate the value of new technologies.
Courses Taught
- PCTH 7123 - Pharmacy Management
- PCTH 7538 - Outcomes Research/Pharmacoeconomics Clerkship
- PCTH 5114 - U.S. Health Care Policy
- PHARM 7552 - Managed Care Elective
- MDCRC 6150 - Foundations in Personalized Health Care
- PCTH 7115 - Multinational Health Care Policy
Service
Department
- Chair of Pharmacotherapy, 2002-2015
College
- Member, College Research Strategy Committee 2020-2021
Awards and Honors
2020 Best Poster Award, AMCP
2020 Faculty of the Year, University of Utah
2019 Teacher of the Year (P3), University of Utah
2018 Top 10 Semi-Finalist, American Dream Ideas Challenge, University of Utah
2018 Nominated Teach of the Yeah (P3 and P4)
2014 Fellow of the Academy of Managed Care Pharmacy
2013 Distinguished Alumnus Award, University of Rhode Island College of Pharmacy
2011 Academy of Managed Care Pharmacy Board of Directors Service Award
2009 International Society for Pharmacoeconomics and Outcome Research Presidential Service Award
2007 National Community Pharmacists Association Top Ten Business Plan Award Student Mentor
2007 American Association of Colleges of Pharmacy Walmart Scholarship Award Mentorship
2006 American Foundation of Pharmaceutical Education (AFPE) Gateway to Research Scholarship Award Mentorship
2006 Merck Leadership Service Award, Utah Pharmacists Association
2003 Journal of Managed Care Pharmacy Award for Excellence Judging Panel
2001 Distinguished Alumnus Award, University of Utah College of Pharmacy
1999 Organizational Contributor Award, International Society of Pharmacoeconomics and Outcomes Research
1998 Novartis Pioneer Award